No Data
No Data
No Data
No Data
No Data
Milestone Pharmaceuticals Announces Data Presentations on Etripamil at Heart Rhythm 2024, 2024 Stanford BioDesign Arrhythmia Technologies Retreat, and ISPOR 2024
MONTREAL and CHARLOTTE, N.C., May 02, 2024 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovati
GlobeNewswireMay 2 20:00
Milestone Pharmaceuticals to Present Data on Etripamil at the Preventative Cardiovascular Nursing Symposium
MONTREAL and CHARLOTTE, N.C., April 17, 2024 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (NASDAQ:MIST) a biopharmaceutical company focused on the development and commercialization of innovative
GlobeNewswireApr 17 20:00
Milestone Pharmaceuticals Announces Etripamil Data Demonstrating Patients' Ability To Self-Manage Recurring PSVT, Presented At The American College Of Cardiology Annual Meeting
Milestone Pharmaceuticals Inc. (NASDAQ:MIST) a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced new clinical data demo
BenzingaApr 8 23:37
Milestone Pharmaceuticals to Present at the 23rd Annual Needham Healthcare Conference
MONTREAL and CHARLOTTE, N.C., April 03, 2024 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today announced that members of its management team will deliver a company presentation
GlobeNewswireApr 3 20:00
Milestone Pharmaceuticals To Present Data On Etripamil At The American College Of Cardiology And European Heart Rhythm Association Annual Conferences
Milestone Pharmaceuticals Inc. (NASDAQ:MIST) a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that it will present d
BenzingaApr 1 20:02
Milestone Pharmaceuticals Disclosed Resubmission Of New Drug Application For Etripamil For Treatment In Paroxysmal Supraventricular Tachycardia
Milestone Pharmaceuticals Disclosed Resubmission Of New Drug Application For Etripamil For Treatment In Paroxysmal Supraventricular Tachycardia
BenzingaMar 28 19:17
No Data
No Data